Salvage Therapy with Capecitabine Plus Weekly Paclitaxel in Heavily Pretreated Advanced Breast Cancer: A Multicenter Phase II Study

By Bari Mario  

American Journal of Cancer, Vol. 4, Iss. 5, 2005-01 ,pp. : 307-313

Adis International

Access to resources Recommend Favorite

Phase I study of a weekly 1h infusion of paclitaxel in patients with unresectable hepatocellular carcinoma

By Strumberg D.   Erhard J.   Harstrick A.   Klaassen U.   Muller C.   Eberhardt W.   Wilke H.   Seeber S.  

European Journal of Cancer, Vol. 34, Iss. 8, 1998-07 ,pp. : 1290-1292

Elsevier

Access to resources Recommend Favorite

A Phase II and Pharmacokinetic Study of Weekly 72-h Topotecan Infusion in Patients with Platinum-Resistant and Paclitaxel-Resistant Ovarian Carcinoma

By Rose P.G.   Gordon N.H.   Fusco N.   Fluellen L.   Rodriguez M.   Ingalls S.T.   Hoppel C.L.  

Gynecologic Oncology, Vol. 78, Iss. 2, 2000-08 ,pp. : 228-234

Elsevier

Access to resources Recommend Favorite

Weekly administration of topotecan and paclitaxel in pretreated advanced cancer patients: a phase I/II study

By Stathopoulos George   Rigatos Sotiris   Christodoulou Christos   Malamos Nikos   Deliyiannis Filippos   Stathopoulos John   Skarlos Dimosthenis  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 3, 2004-09 ,pp. : 259-264

Springer Publishing Company

Access to resources Recommend Favorite

An EORTC-IDBBC phase I study of gemcitabine and continuous infusion 5-fluorouracil in patients with metastatic breast cancer resistant to anthracyclines or pre-treated with both anthracyclines and taxanes

By Awada A.   Biganzoli L.   Cufer T.   Beex L.   Lohrisch C.   Batter V.   Hamilton A.   Nooij M.   Piccart M.  

European Journal of Cancer, Vol. 38, Iss. 6, 2002-01 ,pp. : 773-778

Elsevier

Access to resources Recommend Favorite